Understanding Physician-Pharmaceutical Industry Interactions A Concise Guide 2007 Edition at Meripustak

Understanding Physician-Pharmaceutical Industry Interactions A Concise Guide 2007 Edition

Books from same Author: Shaili Jain

Books from same Publisher: CAMBRIDGE

Related Category: Author List / Publisher List


  • Retail Price: ₹ 6884/- [ 0.00% off ]

    Seller Price: ₹ 6884

Sold By: T K Pandey      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 0.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 0.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)Shaili Jain
    PublisherCAMBRIDGE
    ISBN9780521868648
    Pages160
    BindingHardback
    LanguageEnglish
    Publish YearApril 2007

    Description

    CAMBRIDGE Understanding Physician-Pharmaceutical Industry Interactions A Concise Guide 2007 Edition by Shaili Jain

    Physician-pharmaceutical industry interactions continue to generate heated debate in academic and public domains, both in the United States and abroad. Despite this, recent research suggests that physicians and physicians-in-training remain uninformed of the core issues and are ill-prepared to understand pharmaceutical industry promotion. Furthermore, few medical curricula address this issue, despite warnings of the imperative need to address this gap in the education of tomorrow's physicians. There is a vast medical literature on this topic, but no single, concise resource. This book aims to fill that gap by providing a resource that explains the essential elements of this subject. The text makes the reader more aware of the key ethical issues and allows the reader to be a more savvy interpreter of industry promotion, have a heightened awareness of the public and medical legal consequences of some physician-pharmaceutical industry interactions, and be better equipped to handle real-life encounters with industry.